82172

Apolipoprotein, each

CPT code 82172 describes the laboratory quantitative analysis of an apolipoprotein. Apolipoproteins are the structural protein components of lipoproteins, which are responsible for transporting lipids (such as cholesterol and triglycerides) through the hydrophilic environment of the bloodstream. There are several major classes of apolipoproteins, including Apolipoprotein A (ApoA, the primary protein component of high-density lipoprotein, or HDL), Apolipoprotein B (ApoB, the primary protein component of low-density lipoprotein, LDL, and very-low-density lipoprotein, VLDL), Apolipoprotein C, and Apolipoprotein E. The measurement of specific apolipoproteins provides critical information regarding a patient's lipid metabolism and overall cardiovascular risk, often offering a more accurate predictive value than standard cholesterol measurements alone. For example, ApoB reflects the total number of atherogenic particles in circulation, making it a superior marker for cardiovascular disease risk, especially in patients with metabolic syndrome, diabetes, or those who have achieved LDL cholesterol targets but remain at high residual risk. Conversely, ApoA-I is anti-atherogenic and is essential for reverse cholesterol transport; measuring the ApoB/ApoA-I ratio provides an excellent indicator of the balance between atherogenic and anti-atherogenic particles. The procedure typically involves the collection of a venous blood sample. The serum or plasma is separated and analyzed using advanced automated biochemical methodologies, most commonly immunonephelometry or immunoturbidimetry. In these assays, specific antibodies directed against the target apolipoprotein (e.g., anti-ApoB or anti-ApoA-I) are added to the sample. The resulting antigen-antibody complexes cause light scattering (nephelometry) or changes in light transmission (turbidimetry), which are directly proportional to the concentration of the apolipoprotein in the sample. The analyzer calculates the exact concentration by comparing the optical signal to a standard calibration curve. From a coding and billing perspective, CPT 82172 represents the measurement of a single apolipoprotein. The descriptor specifies 'each,' which implies that if a physician orders tests for both Apolipoprotein A-I and Apolipoprotein B, the code 82172 should be reported twice (or with two units), depending on specific payer policies. Proper clinical documentation justifying the medical necessity of apolipoprotein testing over or alongside standard lipid panels is essential, as these advanced lipid markers are often scrutinized for appropriate utilization.

Clinical Indications

  • Assessment of cardiovascular disease risk, especially in patients with discordant LDL-C and non-HDL-C levels.
  • Evaluation of suspected familial hypercholesterolemia or other genetic dyslipidemias.
  • Risk stratification in patients with a strong family history of premature atherosclerotic cardiovascular disease.
  • Monitoring the efficacy of lipid-lowering therapies, particularly statins and PCSK9 inhibitors.
  • Evaluation of patients with metabolic syndrome, insulin resistance, or type 2 diabetes mellitus where standard lipid panels may underestimate atherogenic particle burden.

Procedure Steps

  1. Venipuncture is performed to collect the patient's blood sample into an appropriate collection tube.
  2. The blood sample is centrifuged in the laboratory to separate the serum or plasma from the cellular components.
  3. The separated sample is placed into an automated clinical chemistry analyzer.
  4. Specific antisera containing antibodies directed against the requested apolipoprotein are added to an aliquot of the sample.
  5. The analyzer measures the resulting immune complexes using immunonephelometry (measuring scattered light) or immunoturbidimetry (measuring transmitted light).
  6. The optical measurement is compared against a standard calibration curve to determine the precise quantitative concentration of the apolipoprotein.
  7. Results are verified, quality controlled, and compiled into a clinical laboratory report for physician review.

Coding Guidelines

  • Report 82172 for each individual apolipoprotein evaluated (e.g., report two units if testing both ApoA-I and ApoB).
  • Ensure clinical documentation clearly reflects the medical necessity for advanced lipid testing beyond standard lipid panels, such as assessing residual risk in high-risk patients.
  • Modifier 59 or 91 may be necessary if multiple independent runs of the exact same apolipoprotein are performed on the same day for a distinct clinical reason, although this is exceedingly rare.
  • Do not unbundle apolipoprotein tests if they are part of a proprietary algorithmic panel code that already includes their measurement.
  • Verify specific payer policies, as some insurers have strict medical necessity criteria for testing apolipoproteins compared to standard lipid panels (CPT 80061).

Associated ICD-10 Codes